CD38 and neoplasm: These findings support previously reported data showing that NK cells with reduced CD38 following exposure to DARA24 or with CD38 shielded by F(ab’)2 fragments23 are protected from DARA-induced fratricide, enabling augmented DARA-mediated ADCC against tumor cells in vitro and in a preclinical animal model.